Results 201 to 210 of about 9,722 (255)

Ubiquitin beyond the proteome: lipids, glycans, metabolites, nucleic acids, and an expanding molecular landscape. [PDF]

Biochem Soc Trans
Endo A, Yoshida Y.
europepmc   +1 more source

FUNCTIONAL CONSEQUENCES OF PARG GENE SILENCING BY RNAI IN MURINE AND HUMAN CELLS. INT. MEETING: POLY(ADP-RIBOSE) POLYMERASES: BENCH TO BEDSIDE .

, 2005
F. R. ALTHAUS, C. BLENN, MALANGA, MARIA
core  

Noncovalent PAR Binding Guides Proteins to PARP1-Mediated PARylation. [PDF]

ACS Chem Biol
Fischbach A, Bangert K, Bürkle A, Mangerich A.   +3 more
europepmc   +1 more source

Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors. [PDF]

NAR Cancer
Buckley-Benbow L, Ozgencil M, Tardocchi A, Agnarelli A, Bellelli R.   +4 more
europepmc   +1 more source

In Vitro Evaluation of PARP1 Inhibitor Olaparib-Cyanine Dye Conjugate for the Treatment of Glioblastoma. [PDF]

ChemMedChem
Dumo C, Faheem, Choi PJ, Pederson NJ, Liu Y, Dragunow M, Park TI, Diehl KL, Jose J.   +8 more
europepmc   +1 more source

Anticancer sensitivities and biological characteristics of HCT116 cells resistant to the selective poly(ADP-ribose) glycohydrolase inhibitor. [PDF]

FEBS Open Bio
Tsuda K, Ogino Y, Sato A.
europepmc   +1 more source

NMR study of human macroPARPs domains: ¹H, ¹³C and ¹⁵N backbone and side-chain chemical shift assignments of hPARP9 macro domain 1 (MD1) in the apo and in the ADPr bound states. [PDF]

Biomol NMR Assign
Moschidi D, Fourkiotis NK, Tsatsouli SA, Tsika AC, Spyroulias GA.   +4 more
europepmc   +1 more source

Interplay between ubiquitination and ADP-ribosylation and the case of dual modification ADPr-Ub. [PDF]

Essays Biochem
Zhu K, Chatrin C, Smith R, Ahel D, Ahel I.   +4 more
europepmc   +1 more source

Structure, function, regulation, evolution, and therapeutic implications of PARP14. [PDF]

Genes Dev
Kar P, Đukić N, Ahel D, Ahel I.
europepmc   +1 more source